Table 2 Association between LPCAT1 expression (based on mRNA expression and protein expression) and clinicopathological factors.
Factors | N = 154 | mRNA expression | Protein expression | ||||
|---|---|---|---|---|---|---|---|
Negative (n = 97) | Positive (n = 57) | P valuea | Negative (n = 110) | Positive (n = 44) | P valuea | ||
Gender | 0.561 | 0.543 | |||||
Male | 107 | 69 (71.13%) | 38 (66.67%) | 78 (68.83%) | 29 (65.91%) | ||
Female | 47 | 28 (28.87%) | 19 (33.33%) | 32 (31.17%) | 15 (34.09%) | ||
Age | 0.961 | 0.702 | |||||
≤60 years | 49 | 31 (31.96%) | 18 (31.58%) | 36 (32.73%) | 13 (29.55%) | ||
>60 years | 105 | 66 (68.04%) | 39 (68.42%) | 74 (67.27%) | 31 (70.45%) | ||
T stage | 0.180 | 0.265 | |||||
T1–2 | 45 | 32 (32.99%) | 13 (22.81%) | 35 (31.82%) | 10 (22.73%) | ||
T3–4 | 109 | 65 (67.01%) | 44 (77.19%) | 75 (68.18%) | 34 (77.27%) | ||
N stage | 0.033 | 0.039 | |||||
N0 | 90 | 63 (64.95%) | 27 (47.37%) | 70 (63.64%) | 20 (45.45%) | ||
N+ | 64 | 34 (35.05%) | 30 (52.63%) | 40 (36.36%) | 24 (54.55%) | ||
Differentiation | 0.376 | 0.920 | |||||
G1 | 57 | 40 (41.24%) | 17 (29.82%) | 42 (38.18%) | 15 (34.09%) | ||
G2 | 87 | 51 (52.58%) | 36 (63.16%) | 61 (55.45%) | 26 (59.09%) | ||
G3 | 10 | 6 (6.19%) | 4 (7.02%) | 7 (6.36%) | 3 (6.82%) | ||
Location | 0.326 | 0.321 | |||||
Upper | 10 | 4 (4.12%) | 6 (10.53%) | 9 (8.18%) | 1 (2.27%) | ||
Middle | 101 | 65 (67.07%) | 36 (63.16%) | 73 (66.36%) | 28 (63.64%) | ||
Lower | 43 | 28 (28.87%) | 15 (26.32%) | 28 (25.45%) | 15 (34.09%) | ||
